USA. A Mexican restaurant. We had not yet ordered anything, and the food was already arriving.
Chips. Salsa. Unrequested. Free.
I stopped the waiter. "We have not earned these."
"They just come with the table, man."
They come with the TABLE. In my land, hospitality is a debt. Every gift creates an obligation, weighed carefully, returned in the proper season with interest of feeling. Here, the gift arrives before you have even proven you can pay for dinner.
This is not an appetizer. This is a declaration: we trust you. Eat.
I ate with the gravity the moment deserved. And then — I must report this calmly — the basket emptied, and a new one appeared.
"Did we…?"
"Refill," the waiter said. "It's bottomless."
Bottomless. They have wells of salsa. The supply lines of this nation are beyond anything my ancestors imagined.
My friend warned me. "Don't fill up on chips, dude."
Too late. I had accepted three baskets. Honor demanded each one be finished — an unfinished gift is an insult. By the time my actual food arrived, I was a ruined man.
I was not hungry. I was not comfortable. I had been defeated by a courtesy.
Generosity that arrives before the request cannot be repaid. It can only be survived.
I know the rule now. I have made my peace with the basket. One basket. Two at the most.
Who am I deceiving. There is no number of baskets I would refuse. The trust of a nation is in that salsa, and I intend to honor all of it.
Today we announced the completion of our acquisition of Soleno Therapeutics, Inc. We welcome our Soleno colleagues to Neurocrine and share their deep commitment to the Prader-Willi syndrome community.
https://t.co/waVERSd0OF
Ahead of tonight's draft, Fernando Mendoza is launching the Mendoza Family Fund to fight multiple sclerosis, a disease that afflicts his mom. Fernando is personally committing $500,000 to MS research at the University of Miami in his hometown. https://t.co/fKrvNXibvV
Today we announced a definitive agreement for Neurocrine to acquire Soleno Therapeutics, a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases. Learn more: https://t.co/pSQtvyg7t0
We’re excited to announce the promotion of Andrew Ratz, Ph.D., to the executive management team as the Chief Technical Operations Officer. Dr. Ratz will now lead the organization’s global development, manufacturing, and supply chain functions to support the long-term delivery of multimodality medicines throughout the product life cycle.
https://t.co/MwSbDZEfYV
Over the last century, defeat has been the near-constant companion of Indiana University football. But with a new coach, new players, and new energy, the Hoosiers shot up to No. 1 in just two years. It has everyone asking: How did they pull this off? 60 Minutes, Sunday.